ACON Aclarion, Inc.

ACON financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1635077 Exchange: Nasdaq SIC: 8071 (Services-Medical Laboratories) Latest filing: 10-Q filed Nov 5, 2026 Data checked: Nov 10, 2026
Showing 3 of 5 annual and 0 of 23 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity Type
Operating
Public Float
$4.39M (Jun 2025)
Industry (SIC)
8071 Services-Medical Laboratories
Incorporated
DE
Fiscal Year End
December (1231)
Phone
833 275 2266
EIN
473324725
Headquarters
BROOMFIELD, CO, 80021
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: Nocimed, Inc. (2015–2021)

▼ Key Metrics (TTM)

As of Sep 30, 2026
Financials
Revenue
$98.56K
Net Income
$-10.11M
Total Assets
$15.83M
Total Equity
$14.81M
Total Debt
-
Free Cash Flow
-
Ratios
Gross Margin
29.1%
Operating Margin
-10789.3%
Net Margin
-10260.2%
Return on Equity
-68.3%
Return on Assets
-63.9%
Current Ratio
14.17x

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

Aclarion, Inc. generated $75.73K of revenue in fiscal 2025, with net loss of $7.23M and an operating cash outflow of $7.16M. The $75.73K revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. Revenue was 65.6% above fiscal 2024 revenue of $45.72K, marking a year-over-year increase. The company reported diluted EPS of -$13.61, adding a shareholder-level measure to the absolute income figures considered below. Diluted shares averaged 532.04K; this is the reported share base over which the company’s diluted per-share earnings were spread. The company employed $13.67M of total assets, the balance-sheet base supporting its current operating and cash-flow results. Revenue equaled 0.01x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

Gross profit was $6.83K, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. Gross profit represented 9.0% of revenue, showing how much of the top line remained after direct costs. The reported operating result was an operating loss of $7.05M, reflecting costs that exceeded gross profit. The bottom-line result was a net loss of $7.23M after operating, financing, tax, and other recognized items. Negative EBITDA totaled $6.82M, confirming that the earnings deficit remained before depreciation and amortization. The company reported a pretax loss of $7.23M, before the effect of income taxes. Income tax expense totaled $0.00, providing the reported tax component that separates pretax and after-tax earnings. The loss-to-equity relationship was 56.4%, placing the bottom-line deficit against shareholder capital. The net loss equaled 52.9% of period-end assets, showing the deficit relative to the asset base. Compared with a $6.99M net loss in fiscal 2024, the current loss increased to $7.23M.

Liquidity and Capital Structure

The company held $13.67M of assets against $837.29K of liabilities and $12.84M of equity, revealing how the asset base was financed. The near-term balance sheet paired $12.40M of current assets with $837.29K of current liabilities at the reporting date. Current assets covered current liabilities by 14.81x, leaving a positive buffer for near-term obligations. Reported cash and equivalents were $12.02M, separating immediately recognizable cash resources from the rest of the current-asset base. The equity-to-assets relationship was 93.9%, placing book capital against the total resource base. Relative to total assets, liabilities measured 6.1%, complementing the separate equity-based view of the company’s capital structure. The cash-to-assets relationship was 87.9%, comparing reported cash and equivalents with the full positive asset balance. Compared with $2.12M in fiscal 2024, the current asset base moved 543.9% and finished higher.

Cash Flow and Earnings Quality

Operating activities used $7.16M of cash, resulting in an operating cash outflow for the year. Capital expenditures used $21.53K in addition to the operating cash outflow, increasing the total cash consumed by operations and investment during the period. The company recorded a $7.19M cash deficit after capital spending for the period. The free-cash-flow deficit equaled 52.6% of total assets, placing the cash shortfall against the company’s resource base. The operating cash outflow widened to $7.16M from $5.27M in fiscal 2024.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for Aclarion, Inc.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $75.73K $45.72K $75.40K
Cost of Revenue $68.90K $84.66K $75.73K
Gross Profit $6.83K $-38.93K $-324
OPERATING EXPENSES
R&D Expense $1.03M $888.77K $873.34K
SG&A Expense $4.12M $3.61M $3.25M
Other Operating Expenses (derived) $1.90M $976.55K $757.00K
Operating Income $-7.05M $-5.51M $-4.88M
NON-OPERATING INCOME / EXPENSE
Interest Expense - $64.08K $110.53K
Interest Income $411.06K $318 -
Other Income/Expense $-4.75K $-49 $-562
Pretax Income $-7.23M $-6.99M $-4.91M
Income Tax $0 $0 $0
Net Income $-7.23M $-6.99M $-4.91M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-13.61 $-7,478.90 $-79,782.00
Diluted Shares 532.04K 943.00 62.00
EBITDA $-6.82M $-5.32M $-4.71M
Depreciation & Amortization $227.41K $193.14K $162.67K
Balance Sheet
ASSETS
Cash & Equivalents $12.02M $453.66K $1.02M
Accounts Receivable $29.68K $18.33K $13.27K
Other Current Assets $10.00K $158.73K $245.03K
Current Assets $12.40M $824.28K $1.29M
PP&E (Net) $24.17K $5.50K $1.78K
Intangible Assets $1.25M $1.29M $1.17M
Noncurrent Assets $1.28M $1.30M $1.17M
Total Assets $13.67M $2.12M $2.46M
LIABILITIES
Accounts Payable $332.96K $531.60K $760.54K
Current Liabilities $837.29K $1.15M $3.19M
Noncurrent Liabilities $0 $0 $0
Total Liabilities $837.29K $1.15M $3.19M
EQUITY
Common Stock - $0 $8
Additional Paid-in Capital $71.33M $52.23M $43.55M
Retained Earnings $-58.50M $-51.26M $-44.28M
Total Equity $12.84M $970.06K $-728.00K
Total Liabilities & Equity $13.67M $2.12M $2.46M
SUPPLEMENTAL
Shares Outstanding 854.37K 1.37K 825.46K
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $-7.16M $-5.27M $-3.65M
Capital Expenditures $21.53K $5.12K $0
Cash from Investing $-203.90K $-321.94K $-119.52K
Cash from Financing $18.95M $5.03M $3.31M
Free Cash Flow $-7.19M $-5.28M $-3.65M
Beginning Cash (CFS) $463.66K $1.03M $1.48M
Net Change in Cash $11.58M $-567.41K $-451.74K
Effect of FX on Cash - - -
Calculated Ending Cash $12.04M $463.66K $1.03M
Cash per BS $12.02M $453.66K $1.02M
Cash scope difference (CFS − BS) $25.00K $10.00K $10.00K
Cash per CFS $12.04M $463.66K $1.03M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is Aclarion, Inc.'s annual revenue?

Aclarion, Inc. reported $98.56K in revenue for trailing twelve months (ending September 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is Aclarion, Inc. profitable?

No. Aclarion, Inc. reported $-10.11M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.